Overview A Renal Impairment Study for PF-06651600 Status: Terminated Trial end date: 2020-03-31 Target enrollment: Participant gender: Summary This is a Phase 1 non-randomized, open-label, parallel cohort study of PF-06651600 in subjects with severe renal impairment and subjects without renal impairment (Part 1) and in subjects with mild and moderate renal impairment (Part 2). Phase: Phase 1 Details Lead Sponsor: Pfizer